Because GAS6 has the capacity to stimulate AXL-mediated chemotaxis, malignant bladder cancer cells can utilize GAS6-AXL signaling to recruit PD1hi CD200hi CD4+ exhausted T cells and indirectly promote EMT. Here, AXL is linked to urinary bladder carcinoma.